excess
environment
industri
develop
creat
hazard
condit
viral
diseas
eg
middl
east
respiratori
syndrom
mer
particul
matter
air
pollut
classifi
carcinogen
human
iarc
group
thu
import
build
strong
immun
system
becom
import
good
health
demand
health
supplement
help
improv
immun
system
rapidli
increas
close
correl
immun
respons
inflamm
immun
decreas
bodi
easili
expos
infecti
noninfecti
inflammatori
diseas
ulcer
coliti
uc
type
inflammatori
bowel
diseas
ibd
estim
million
peopl
unit
state
suffer
ibd
approxim
half
uc
exact
caus
uc
unknown
appear
relat
combin
genet
environment
factor
goal
convent
ibd
therapi
mainli
downregul
aberr
immun
respons
inflammatori
cascad
convent
drug
ibd
includ
corticosteroid
acid
mesalazin
drug
undesir
side
effect
especi
steroid
therapi
caus
infertil
development
disabl
ibd
patient
present
divers
symptom
throughout
cours
diseas
symptom
directli
relat
diseas
activ
other
may
consequ
therapi
diseas
impos
substanti
burden
patient
significantli
impact
function
healthrel
qualiti
life
spite
advanc
modern
medic
scienc
tradit
herbal
medicin
continu
wide
use
health
mainten
diseas
prevent
even
diseas
treatment
china
japan
korea
thousand
year
previou
studi
shown
ibd
patient
turn
complementari
altern
medicin
cynanchum
genu
includ
approxim
speci
distribut
worldwid
includ
east
africa
mediterranean
tropic
zone
europ
subtrop
temper
zone
asia
mani
cynanchum
speci
use
tradit
medicin
korea
prevent
treat
variou
diseas
rheumat
arthriti
geriatr
vascular
ischemiainduc
diseas
root
cynanchum
wilfordii
hemsley
refer
cynanchi
wilfordii
radix
korean
pharmacopoeia
c
wilfordii
receiv
substanti
attent
tradit
herbal
medicin
use
treat
variou
diseas
mani
potenti
benefici
effect
antitumor
antioxid
antiinflammatori
effect
guard
diabet
mellitu
gastric
disord
neuron
damag
hypercholesterolemia
caus
vascular
relax
effect
plant
wellknown
contain
biolog
activ
compound
includ
gagaminin
glycosid
wilfosid
cynauricuosid
well
sarcotin
penupogenin
cynandion
polysaccharid
plant
origin
proven
import
class
natur
bioactiv
product
recent
year
previou
studi
demonstr
possess
antitumor
immunityenhanc
anticoagul
antithrombot
antioxid
antiinflammatori
activ
previous
show
highmolecularweight
fraction
hmf
c
wilfordii
exert
immuneenhanc
effect
immunosuppress
induc
cyclophosphamid
macrophag
effect
attribut
crude
polysaccharid
howev
antiinflammatori
effect
polysaccharid
c
wilfordii
dextran
sulfat
sodium
dss
induc
mous
model
coliti
relat
mechan
action
yet
report
polysaccharid
may
also
antiinflammatori
function
investig
antiinflammatori
effect
polysaccharid
c
wilfordii
lipopolysaccharid
lp
induc
raw
macrophag
dssinduc
chronic
coliti
mice
hmfo
prepar
previous
describ
briefli
hmfo
obtain
highmolecularweight
fraction
c
wilfordii
process
polyethersulfon
ultrafiltr
membran
molecular
weight
mw
cutoff
kda
crossflow
filtrat
system
highmolecularweight
fraction
precipit
addit
volum
ethanol
mixtur
allow
stand
overnight
centrifug
rpm
min
obtain
precipit
precipit
lyophil
produc
hmfo
chemic
monosaccharid
composit
hmfo
analyz
previou
studi
molecular
weight
rang
hmfo
estim
kda
experi
perform
use
femal
balbc
mice
acclimat
period
mice
purchas
koatech
anim
inc
pyeongtaek
korea
maintain
temperatur
lightcontrol
facil
free
access
standard
rodent
chow
water
experiment
protocol
complianc
guid
principl
care
use
laboratori
anim
ethic
committe
korea
food
research
institut
well
intern
accept
principl
laboratori
anim
use
care
found
us
guidelin
nih
public
number
revis
twentyf
mice
weigh
divid
group
mice
per
group
mice
group
untreat
control
receiv
regular
drink
water
mice
group
receiv
wv
dss
mw
da
mp
biomed
solon
oh
usa
drink
water
day
receiv
regular
water
day
mice
group
dssinduc
coliti
treat
oral
hmfo
mgkg
respect
day
day
mice
group
dssinduc
coliti
treat
intragastr
mgkg
refer
drug
bodi
weight
food
intak
stool
consist
presenc
gross
bleed
assess
daili
organ
weight
colon
length
determin
sacrific
dai
calcul
score
weight
loss
diarrhea
rectal
bleed
base
previous
describ
score
system
shown
tabl
weight
loss
defin
differ
initi
final
weight
diarrhea
defin
absenc
fecal
pellet
format
presenc
continu
fluid
fecal
materi
colon
rectal
bleed
assess
base
presenc
visibl
blood
diarrhea
gross
rectal
bleed
dai
valu
calcul
combin
score
weight
loss
stool
constanc
bleed
mice
sacrif
end
experi
colon
separ
proxim
rectum
close
pass
pelvi
sternum
colon
length
measur
ileocec
junction
proxim
rectum
accumul
mpo
colon
tissu
measur
marker
neutrophil
influx
colon
colon
tissu
thaw
homogen
lysi
buffer
subsequ
homogen
centrifug
min
result
supernat
assay
mpo
assay
use
colorimetr
activ
assay
kit
sigma
st
loui
mo
usa
accord
manufactur
recommend
protocol
entir
colon
dissect
flush
icecold
phosphatebuff
salin
pb
sampl
rectum
obtain
fix
neutralbuff
formalin
sigmaaldrich
h
room
temperatur
embed
paraffin
section
histolog
evalu
paraffinembed
tissu
cut
section
stain
hematoxylin
eosin
h
e
sever
coliti
evalu
h
estain
section
independ
observ
blind
experiment
condit
accord
modifi
criteria
result
summar
tabl
perform
immunohistochem
analysi
express
colon
tissu
tissu
section
deparaffin
use
xylen
dehydr
gradient
alcohol
solut
exclud
endogen
peroxidas
activ
section
incub
min
incub
primari
antibodi
dilut
protein
interest
h
detect
system
visual
antimous
antibodi
dako
glostrup
denmark
appli
accord
manufactur
instruct
slide
stain
liquid
diaminobenzidin
tetrahydrochlorid
dab
highsensit
substratechromogen
system
dako
imag
slide
visual
olympu
light
microscop
raw
cell
grown
dulbecco
modifi
eagl
medium
dmem
contain
fetal
bovin
serum
mgml
streptomycin
uml
penicillin
cell
seed
plate
densiti
cellswel
normal
dmem
pretreat
indic
concentr
hmfo
h
cell
incub
lp
h
inhibitori
effect
hmfo
product
determin
use
griess
reagent
enzymelink
immunosorb
assay
elisa
kit
r
system
minneapoli
mn
usa
respect
accord
manufactur
instruct
cell
cultur
supernat
mous
sera
collect
level
measur
elisa
kit
bd
bioscienc
san
jose
ca
target
either
protein
accord
manufactur
protocol
equal
amount
lysat
resolv
sodium
dodecylpolyacrylamid
gel
electrophoresi
transfer
nitrocellulos
membran
blot
visual
use
enhanc
chemiluminesc
system
amersham
bioscienc
inc
piscataway
nj
usa
follow
exposur
xray
film
fuji
photo
film
co
ltd
tokyo
japan
previous
describ
primari
antibodi
ino
total
phosphoryl
jnk
phosphoryl
total
jnk
total
purchas
santa
cruz
biotechnolog
dalla
tx
usa
antibodi
phosphoryl
phosphoryl
phosphoryl
purchas
cell
signal
technolog
inc
beverli
usa
total
cellular
rna
isol
trizol
ls
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
cdna
synthes
use
cdna
synthesi
kit
thermo
scientif
sankt
leonrot
germani
accord
manufactur
protocol
targetspecif
rtpcr
primer
design
ino
tnfa
tabl
raw
macrophag
treat
variou
concentr
hmfo
h
prior
lp
addit
macrophag
collect
h
activ
lp
wash
one
time
pb
ph
nuclear
extract
isol
use
neper
nuclear
cytoplasm
extract
reagent
accord
manufactur
instruct
pierc
rockford
il
detect
bind
nuclear
protein
treat
accord
instruct
transcript
factor
assay
kit
abcam
cambridg
usa
optic
densiti
determin
nm
elisa
reader
dssinduc
coliti
mice
wellestablish
preclin
model
exhibit
mani
phenotyp
featur
human
ulcer
coliti
day
mice
dssinduc
coliti
show
bodi
weight
loss
compar
weight
mice
control
group
mice
treat
mgkg
hmfo
show
loss
figur
also
day
dai
score
mice
dsstreat
group
point
higher
mice
control
group
treatment
hmfo
attenu
dssmediat
increas
dai
score
day
point
mice
treat
mgkg
mgkg
hmfo
respect
figur
b
colon
length
shorten
reflect
extent
colon
damag
occur
acut
dssinduc
coliti
averag
colon
length
approxim
mm
normal
control
group
wherea
decreas
mm
dsstreat
group
mice
treat
high
mgkg
low
mgkg
dose
hmfo
show
significantli
longer
colon
length
mice
dsstreat
group
mm
group
treat
mgkg
hmfo
resp
versu
mm
dsstreat
group
figur
c
result
demonstr
hmfo
treatment
reduc
sever
dssinduc
acut
coliti
histolog
analysi
perform
assess
therapeut
effect
hmfo
colon
inflamm
mucos
thick
regard
indic
normal
mucos
condit
treatment
dss
caus
epitheli
injuri
infiltr
inflammatori
cell
mast
cell
colon
inflamm
mucos
injuri
assess
patholog
examin
colon
h
e
stain
repres
result
shown
figur
repres
colon
tissu
section
mice
control
group
show
intact
surfac
epithelium
cryptal
gland
stroma
submucosa
howev
colon
section
dsstreat
mice
show
branch
crypt
cryptiti
decreas
number
crypt
goblet
cell
inflammatori
cell
infiltr
extens
submucos
edema
contrast
hmfo
treatment
improv
sign
histolog
damag
abnorm
crypt
crypt
loss
inflammatori
cell
infiltr
figur
mice
treat
dss
alon
significantli
elev
histolog
score
compar
healthi
control
mice
howev
histolog
score
decreas
approxim
dsstreat
group
treat
highest
hmfo
concentr
mgkg
figur
b
result
suggest
hmfo
treatment
protect
acut
dssinduc
coliti
evalu
protect
effect
hmfo
leukocyt
infiltr
colon
tissu
measur
level
mpo
marker
leukocyt
infiltr
colon
tissu
mpo
enzym
produc
mainli
polymorphonuclear
leukocyt
specif
granulocyt
lysosom
therefor
mpo
directli
correl
number
neutrophil
shown
figur
c
dsstreat
mice
show
signific
increas
mpo
activ
compar
control
mice
increas
drastic
decreas
hmfotreat
group
therefor
increas
mpo
activ
tissu
induc
dss
correl
develop
colon
inflamm
hmfo
administr
markedli
suppress
mpo
accumul
colon
tissu
key
characterist
dssinduc
coliti
increas
secret
proinflammatori
cytokin
serum
thu
measur
serum
cytokin
level
studi
serum
level
significantli
higher
dsstreat
group
control
group
howev
level
mice
treat
hmfo
mgkg
lower
dsstreat
group
figur
serum
level
also
increas
dsstreat
mice
compar
normal
control
group
hmfotreat
mice
lower
serum
concentr
dsstreat
mice
figur
b
moreov
immunohistochemistri
analysi
indic
hmfo
mgkg
markedli
revers
increas
cell
brown
stain
colon
mucosa
dssinduc
mice
figur
c
high
level
proinflammatori
cytokin
product
major
characterist
dssinduc
coliti
dssinduc
acut
coliti
enorm
infiltr
appear
inflammatori
lesion
mainli
consist
b
lymphocyt
macrophag
neutrophil
produc
variou
proinflammatori
cytokin
includ
colon
patient
ibd
markedli
increas
number
mast
cell
macrophag
observ
cell
might
contribut
abnorm
product
inflammatori
cytokin
mediat
effect
hmfo
express
inflammatori
protein
ino
cytosol
extract
colon
coliti
mice
detect
western
blot
analysi
shown
figur
b
ino
express
level
significantli
increas
colon
tissu
dsstreat
mice
compar
normal
mice
howev
hmfo
administr
remark
reduc
ino
protein
upregul
significantli
decreas
dssinduc
express
normal
level
differ
dose
hmfo
figur
b
ino
enzym
repres
import
molecular
target
treatment
prevent
ibd
express
activ
associ
diseas
sever
suggest
potenti
antiinflamm
drug
target
activ
inflamm
bacteria
enter
lamina
propria
due
cell
destruct
increas
permeabl
inflammatori
cytokin
bacteri
antigen
induc
drive
transcript
ino
proinflammatori
enzym
also
upregul
murin
experiment
coliti
activ
human
ibd
data
clearli
demonstr
colon
damag
associ
elev
express
ino
protein
hmfo
administr
potent
downregul
express
level
similar
studi
pomegran
polyphenol
resveratrol
decreas
ino
overexpress
murin
experiment
coliti
major
transcript
factor
regul
express
multipl
inflammatori
immun
gene
play
key
role
host
defens
chronic
inflammatori
diseas
activ
mucos
cell
ibd
patient
experiment
coliti
model
thu
may
ideal
target
uc
therapi
therefor
effect
hmfo
activ
mice
dssinduc
coliti
investig
dss
administr
significantli
elev
phosphoryl
level
colon
tissu
compar
control
group
howev
hmfo
treatment
drastic
attenu
phosphoryl
compar
hmfotreat
control
mice
figur
c
result
suggest
hmfo
inhibit
activ
transcript
factor
mice
dssinduc
coliti
may
effect
promis
treatment
uc
effect
hmfo
lpsinduc
product
raw
macrophag
investig
measur
releas
cultur
supernat
use
griess
reagent
shown
figur
hmfo
significantli
decreas
lpsinduc
product
dosedepend
manner
inhibit
hmfo
nontox
concentr
synthes
ino
wellknown
proinflammatori
mediat
involv
variou
physiolog
patholog
process
suppress
product
suggest
new
pharmacolog
strategi
treat
inflammationrel
diseas
shown
figur
b
c
ino
express
mrna
protein
level
significantli
increas
follow
lp
stimul
howev
ino
mrna
protein
level
lpsstimul
raw
macrophag
significantli
reduc
treatment
hmfo
result
indic
hmfo
suppress
product
suppress
ino
gene
express
lpsinduc
raw
macrophag
ino
gene
primari
regul
product
macrophag
ino
inhibitor
found
attenu
osteoarthr
periodont
septic
shock
chronic
inflammatori
diseas
examin
whether
product
suppress
hmfo
lpsstimul
raw
cell
lp
significantli
increas
product
compar
basal
product
level
absenc
lp
treatment
hmfo
significantli
inhibit
lpsinduc
product
concentrationdepend
manner
figur
mrna
express
protein
level
increas
markedli
respons
lp
treatment
hmfo
inhibit
lpsactiv
gene
protein
express
dosedepend
manner
figur
e
f
gener
play
import
role
inflammatori
respons
lp
treatment
result
elev
level
inflamm
site
also
activ
high
concentr
intensifi
inflammatori
respons
mani
chronic
inflammatori
disord
examin
abil
hmfo
inhibit
express
major
proinflammatori
cytokin
measur
product
untreat
hmfopretr
lpsstimul
raw
macrophag
treatment
hmfo
inhibit
lpsinduc
figur
product
figur
c
dosedepend
manner
next
investig
effect
hmfo
lpsinduc
gene
express
raw
macrophag
mrna
level
upregul
lp
stimul
treatment
hmfo
suppress
figur
b
figur
mrna
express
impli
hmfo
could
block
transcript
activ
induc
inflammationregul
transcript
factor
examin
inhibitori
effect
hmfo
activ
measur
nuclear
cytoplasm
ikk
level
western
blot
shown
figur
stimul
raw
macrophag
lp
increas
nuclear
transloc
howev
effect
inhibit
hmfo
treatment
find
indic
hmfo
decreas
activ
block
nuclear
transloc
via
phosphoryl
figur
c
ubiquit
transcript
factor
constitut
express
mani
cell
type
includ
cell
monocytemacrophag
lineag
nuclear
transloc
involv
initi
transcript
sever
gene
includ
ino
mapk
play
critic
role
regul
cell
growth
differenti
cellular
respons
cytokin
modul
activ
investig
whether
hfmodepend
inhibit
activ
product
occur
mapk
pathway
examin
effect
hmfo
lpsinduc
phosphoryl
jnk
erk
western
blot
analysi
shown
figur
c
pretreat
cell
hmfo
inhibit
lpsinduc
phosphoryl
jnk
erk
concentrationdepend
manner
result
suggest
hmfo
may
inhibit
activ
product
raw
macrophag
suppress
mapk
phosphoryl
summari
result
suggest
hmfo
inhibit
express
sever
cytokin
enzym
involv
inflamm
ino
attenu
mapk
raw
macrophag
furthermor
hmfo
amelior
patholog
characterist
coliti
shorten
colon
length
significantli
reduc
serum
level
proinflammatori
cytokin
histolog
analysi
indic
hmfo
improv
sign
histolog
damag
abnorm
crypt
crypt
loss
inflammatori
cell
infiltr
induc
dss
addit
hmfo
inhibit
ino
protein
express
level
phosphoryl
colon
tissu
mice
dssinduc
coliti
result
indic
hmfo
attenu
inflamm
vitro
vivo
primarili
inhibit
activ
thu
find
indic
hmfo
effect
promis
remedi
ibd
coliti
